NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three... Read more.
Fluor Reports First Quarter 2024 Results
New awards of $7.0 billion, 97% reimbursable Ending backlog increased 28% to $32.7 billion, 80% reimbursable Expect divestiture of non-core businesses by end of... Read more.
Global Blue Announces Date For Q4 and FY 2023/24 Financial Results
SIGNY, Switzerland–(BUSINESS WIRE)–On June 5, 2024, before the market opens, Global Blue Group Holding AG (NYSE: GB and GB.WS) will release its financial... Read more.
MarketAxess Announces Monthly Volume Statistics for April 2024
NEW YORK–(BUSINESS WIRE)–MarketAxess Holdings Inc. (Nasdaq: MKTX), the operator of a leading electronic trading platform for fixed-income securities,... Read more.
nVent Electric plc First Quarter 2024 Financial Results Available on Company’s Website
LONDON–(BUSINESS WIRE)–nVent Electric plc (NYSE:NVT) (“nVent”), a global leader in electrical connection and protection solutions, reported first... Read more.
Ault Alliance Completes Final Distribution of TOG Securities
Ault Alliance Distributed an Aggregate of 140 Million Shares of Common Stock and Warrants to Purchase 140 Million Shares of Common Stock of TurnOnGreen, Inc. to... Read more.
Owens & Minor Reports First Quarter 2024 Financial Results
Gross Margin Expansion of 79 Basis Points Adjusted EPS Growth of Nearly Four Times with GAAP EPS Loss of $(0.29) and Adjusted EPS of $0.19 Investments Outlined at... Read more.
AG Mortgage Investment Trust, Inc. Reports First Quarter 2024 Results
NEW YORK–(BUSINESS WIRE)–AG Mortgage Investment Trust, Inc. (“MITT,” “we,” the “Company,” or “our”) (NYSE:... Read more.
Essent Group Ltd. Announces First Quarter 2024 Results and Declares Quarterly Dividend
HAMILTON, Bermuda–(BUSINESS WIRE)–Essent Group Ltd. (NYSE: ESNT) today reported net income for the quarter ended March 31, 2024 of $181.7 million or... Read more.
Arcturis and Oxford University Hospitals NHS Foundation Trust announce 3-year programme to deliver highly enriched Real-World Data supporting generation of evidence for the development and approval of novel cancer therapies.
OXFORD, England–(BUSINESS WIRE)–Arcturis Data Limited (“Arcturis”), a UK leader in Real World Data and Evidence, and Oxford University Hospitals... Read more.